COMMUNIQUÉS West-GlobeNewswire

Aegis Awarded Patent for Fast Acting Nasal Spray Opioid Blockers and Pain Medications

22/02/2018 - 14:00

SAN DIEGO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 9,895,444 providing non-invasive metered nasal spray delivery of multiple opioid blockers such [...]

Hemostemix Signs Manufacturing Agreement with Aspire Health Science

22/02/2018 - 14:00

CALGARY, Alberta, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE:HEM) is pleased to announce it has finalized the terms of a contract manufacturing services agreement [...]

Emerald Health Therapeutics Named as #1 2018 TSX Venture 50™ Performer

22/02/2018 - 14:00

VICTORIA, British Columbia, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V: EMH ) (OTCQX:EMHTF) ("Emerald") has achieved the #1 ranking in the 2018 TSX Venture 50™ for the clean technology [...]

Scythian Biosciences Corp. Announces Ringing of the Nasdaq Stock Market Closing Bell

22/02/2018 - 14:00

TORONTO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTCQB:SCCYF) is pleased to announce that the Company will ring the closing bell at [...]

Amedisys-Availity Relationship Yields Faster Payor Authorizations

22/02/2018 - 13:30

BATON ROUGE, La., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Thanks to a new relationship with Availity, LLC (“Availity”), Amedisys, Inc. (NASDAQ: AMED ), one of the nation’s leading home health, hospice and personal care [...]

Actinium Pharmaceuticals Announces Commencement of Rights Offering Subscription Period

22/02/2018 - 13:30

- Subscription period expected to end on March 2, 2018 at 5:00 PM ET NEW YORK, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") , announced today that [...]

XORTX Therapeutics Appoints Dave Matthews CFO

22/02/2018 - 13:30

CALGARY, Alberta, Feb. 22, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney [...]

Repligen Reports Fourth Quarter 2017 Financial Results, Provides Guidance for 2018

22/02/2018 - 13:30

- Revenue for 2017 increased by 35% to $141.2 million (36% at constant currency) - - GAAP EPS for 2017 more than doubled to $0.72, including a positive $0.24 impact of U.S. tax reform - - Spectrum outperforms on revenue [...]

Shire Recognizes Rare Disease Day 2018 with Global Initiatives Focused on Reducing the Time to Diagnosis

22/02/2018 - 13:01

Shire Recognizes Rare Disease Day 2018 with Global Initiatives Focused on Reducing the Time to Diagnosis Diagnosis is one of the most important issues affecting health, longevity and well-being for rare disease patients [...]

Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides a Business Update

22/02/2018 - 13:00

XERMELO ® (telotristat ethyl) U.S. Net Sales Since March 2017 Launch Reach $15.1 Million Regulatory Filings for Sotagliflozin in Patients with Type 1 Diabetes Expected in First Quarter of 2018 THE WOODLANDS, Texas, Feb [...]

Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2017 Earnings Release Date and Conference Call

22/02/2018 - 13:00

NASHVILLE, Tenn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that the Company will release [...]

Natus Announces $30 Million Share Repurchase Program

22/02/2018 - 13:00

PLEASANTON, Calif. , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) announced that its Board of Directors has authorized the repurchase of up to $30 million of the Company's common stock. [...]

DiaMedica Announces First Enrollment in its PHASE 2 “REMEDY” TRIAL for Acute Ischemic Stroke

22/02/2018 - 13:00

DM199 may offer an effective and safe treatment with a significantly longer treatment window (24 hours) compared to the current standard of care REMEDY trial lead by prominent neurologist Dr. Bruce Campbell, its [...]

RedHill Biopharma Provides Fourth Quarter and Full-Year 2017 Investor Update

22/02/2018 - 13:00

Key Highlights: Top-line results from the Phase III study with RHB-104 for Crohn’s disease expected in mid-2018 Top-line results from the confirmatory Phase III study with TALICIA ® for H. pylori infection expected in [...]

LHC Group and Almost Family Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger

22/02/2018 - 13:00

LAFAYETTE, La. and LOUISVILLE, Ky., Feb. 22, 2018 (GLOBE NEWSWIRE) -- LHC Group, Inc. (“LHC Group”) (NASDAQ: LHCG ) and Almost Family, Inc. (“Almost Family”) (NASDAQ: AFAM ) announced today that the waiting period under [...]

Loxo Oncology to Announce Fourth Quarter and Year-End 2017 Financial Results

22/02/2018 - 12:45

STAMFORD, Conn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO ), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers [...]

Achillion Announces Restructuring to Advance Corporate Strategy; Announces 2017 Fourth Quarter and Full Year Financial Results

22/02/2018 - 12:05

Corporate restructuring expected to enable Achillion to focus on goal of advancing its clinical and late-stage preclinical portfolio while maintaining a strong balance sheet Joseph Truitt, Chief Operating Officer, [...]

Biohit GastroPanel® test helps reducing unnecessary gastroscopies in pre-operative evaluation of the patients referred for bariatric surgery

22/02/2018 - 12:00

Biohit Oyj Press release, 22nd February, 2018 at 1:00 p.m. local time (EET) Bariatric (obesity) surgery has become increasingly common in Western countries as the ultimate means to reduce the excess weight in patients [...]

Sernova’s Cell Pouch Regenerative Medicine Clinical Trial for Patients with Type 1 Diabetes Supported with Continuous Glucose Monitoring Systems

22/02/2018 - 12:00

LONDON, Ontario, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V: SVA ) (OTCQB:SEOVF) (FSE:PSH), a clinical stage company developing regenerative medicine technologies for the treatment of chronic diseases [...]